TaiGen Biopharmaceuticals Holdings Limited (TPEX: 4157)
14.50
+0.55 (3.94%)
Sep 10, 2024, 1:30 PM CST
TaiGen Biopharmaceuticals Holdings Revenue
TaiGen Biopharmaceuticals Holdings had revenue of 121.49M TWD in the quarter ending June 30, 2024, with 22.14% growth. This brings the company's revenue in the last twelve months to 149.45M, up 15.77% year-over-year. In the year 2023, TaiGen Biopharmaceuticals Holdings had annual revenue of 123.13M with 239.87% growth.
Revenue (ttm)
149.45M
Revenue Growth
+15.77%
P/S Ratio
72.10
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 123.13M | 86.90M | 239.87% |
Dec 31, 2022 | 36.23M | -1.26B | -97.20% |
Dec 31, 2021 | 1.29B | 1.27B | 5,426.95% |
Dec 31, 2020 | 23.42M | 3.11M | 15.30% |
Dec 31, 2019 | 20.31M | -9.30M | -31.41% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition